FMC CEO sees slight decline in U.S. pay from 'rebasing'

FRANKFURT, Feb 26 (Reuters) - Fresenius Medical Care expects only a slight reduction in U.S. reimbursement for services and drugs it provides to its dialysis patients from a ruling expected later this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.